Inflammatory brain changes in Lyme borreliosis A report on three patients and review of literature

Brain

Volumn 119, Issue 6, 1996, Pages 2143-2154

  Oksi, J ^a,b,d   Kalimo, H ^a   Marttila, R J ^a   Marjamaki M ^a   Sonninen, P ^a   Nikoskelainen, J ^a   Viljanen, M K ^c,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Depts Med Microbiol and Dermatol   (Finland)

Author keywords

Borrelia burgdorferi; Lyme disease; Neuroborreliosis; Neuropathology; Vasculitis

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; BACTERIAL DNA; CEFTRIAXONE; DOXYCYCLINE; PROBENECID;

ADULT; ARTICLE; BORRELIA BURGDORFERI; BRAIN VASCULITIS; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; ENCEPHALITIS; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; MALE; MEDICAL LITERATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; WHITE MATTER;

ADULT; BORRELIA BURGDORFERI GROUP; BRAIN; DNA, BACTERIAL; ENCEPHALITIS; FEMALE; HUMANS; LYME DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; VASCULITIS;

EID: 0030476871     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.6.2143     Document Type: Article

References (82)

1. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. [Review]. Clin Infect Dis 1994; 19: 1092-9.
2. Backenson PB, Coleman JL, Benach JL. Borrelia burgdorferi shows specificity of binding to glycosphingolipids. Infect Immun 1995; 63: 2811-7.
3. Baig S, Olsson T, Höjeberg B, Link H. Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis. Neurology 1991; 41: 581-7.
4. Barthold SW, Moody KD, Terwilliger GA, Duray PH, Jacoby RO, Steere AC. Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis 1988; 157: 842-6.
5. Barthold SW, Sidman CL, Smith AL. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg 1992; 47: 605-13.
6. Belman AL, Coyle PK, Roque C, Cantos E. MRI findings in children infected by Borrelia burgdorferi. Pediatr Neurol 1992; 8: 428-31.
7. Benach JL, Garcia Monco JC. Aspects of the pathogenesis of neuroborreliosis. In: Schutzer SE, editor. Lyme disease: molecular and immunologic approaches. New York: Cold Spring Harbor Laboratory Press, 1992: 1-10.
8. Burgdorfer W, Gage KL. Susceptibility of the hispid cotton rat (Sigmodon hispidus) to the Lyme disease spirochete (Borrelia burgdorferi). Am J Trop Med Hyg 1987; 37: 624-8.
9. Camponovo F, Meier C. Neuropathy of vasculitic origin in a case of Garin-Boujadoux-Bannwarth syndrome with positive borrelia antibody response. J Neurol 1986; 233: 69-72.
10. Clavelou P, Vernay D, Cuoq N, Soubrier M, D'Hombres A, Dordain G, Tournilhac M. Demyelinating involvement in Borrelian neuropathies. [French]. Rev Neurol (Paris) 1993; 149: 320-5.
11. Comstock LE, Thomas DD. Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect Immun 1989; 57: 1626-8.
12. Coyle PK. Borrelia burgdorferi antibodies in multiple sclerosis patients. Neurology 1989; 39: 760-1.
13. Coyle PK, Dattwyler R. Spirochetal infection of the central nervous system. [Review]. Infect Dis Clin North Am 1990; 4: 731-16.
14. Coyle PK, Krupp LB, Doscher C. Significance of reactive Lyme serology in multiple sclerosis. Ann Neurol 1993; 34: 745-7.
15. Duray PH. Clinical pathologic correlations of Lyme disease. Rev Infect Dis 1989a; 11 Suppl 6: S1487-93.
16. Duray PH. Histopathology of clinical phases of human Lyme disease. [Review], Rheum Dis Clin North Am 1989b; 15: 691-710.
17. Fikrig E, Barthold SW, Marcantonio N, Deponte K, Kantor FS, Flavell RA. Roles of OspA, OspB. and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect Immun 1992; 60: 657-61.
18. Garcia-Monco JC, Benach JL. Lyme neuroborreliosis. [Review]. Ann Neurol 1995; 37: 691-702.
19. Garcia-Monco JC, Fernandez-Villar B, Benach JL. Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J Infect Dis 1989; 160: 497-506.
20. Garcia-Monco JC, Villar BF, Alen JC, Benach JL. Borrelia burgdorferi in the central nervous system: experimental and clinical evidence for early invasion. J Infect Dis 1990; 161: 1187-93.
21. Garcia-Monco JC, Fernandez-Villar B, Rogers RC, Szczepanski A, Wheeler CM, Benach JL. Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology 1992; 42: 1341-8.
22. Guy EC, Turner AM. Seronegative neuroborreliosis [letter]. Lancet 1989; 1: 441.
23. Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 1991; 41: 1571-82.
24. Hammers-Berggren S, Grondahl A, Karlsson M, von Arbin M, Carlsson A, Stiernstedt G. Screening for neuroborreliosis in patients with stroke. Stroke 1993; 24: 1393-6.
25. Hance AJ, Grandchamp B, Lévy-Frébault V, Lecossier D, Rauzier J, Bocart D, et al. Detection and identification of mycobacteria by amplification of mycobacterial DNA. Mol Microbiol 1989; 3: 843-9.
26. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol 1991; 30: 197-205.
27. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992; 115: 399-423.
28. He Q, Marjamäki M, Soini H, Mertsola J, Viljanen MK. Primers are decisive for sensitivity of PCR. Biotechniques 1994; 17: 82-7.
29. Johnson RC, Marek N, Kodner C. Infection of Syrian hamsters with Lyme disease spirochetes. J Clin Microbiol 1984; 20: 1099-101.
30. Johnston YE, Duray PH, Steere AC, Kashgarian M, Buza J, Malawista SE, et al. Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol 1985; 118: 26-34.
31. Karma A, Seppälä I, Mikkilä H, Kaakkola S, Viljanen M, Tarkkanen A. Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol 1995; 119: 127-35.
32. Klempner MS, Noring R, Epstein MP, McCloud B, Hu R, Limentani SA, et al. Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 1995; 171: 1258-65.
33. Kohler J, Kern U, Kasper J, Rhese-Kupper B, Thoden U. Chronic central nervous system involvement in Lyme borreliosis. Neurology 1988; 38: 863-7.
34. Krüger WH, Pulz M. Detection of Borrelia burgdorferi in cerebrospinal fluid by the polymerase chain reaction. J Med Microbiol 1991; 35: 98-102.
35. Kuntzer T, Bogousslavsky J, Miklossy J, Steck AJ, Janzer R, Regli F. Borrelia rhombencephalomyelopathy. Arch Neurol 1991; 48: 832-6.
36. Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection [published erratum appears in JAMA 1992; 268: 872 ] |see comments]. JAMA 1992; 267: 1364-7. Comment in: JAMA 1992; 268: 872.
37. Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection [published erratum appears in JAMA 1992; 268: 872 ] |see comments]. JAMA 1992; 267: 1364-7. Comment in: JAMA 1992; 268: 872.
38. MacDonald AB, Miranda JM. Concurrent neocortical borreliosis and Alzheimer's disease. Hum Pathol 1987; 18: 759-61.
39. May EF, Jabbari B. Stroke in neuroborreliosis. [Review]. Stroke 1990; 21: 1232-5.
40. Meier C, Grehl H. Vasculitic neuropathy in the Garin-Bujadoux-Bannwarth syndrome. A contribution to the understanding of the pathology and pathogenesis of the neurological complications in Lyme borreliosis. [German] Dtsch Med Wochenschr 1988; 113: 135-8.
41. Meurcrs B, Kohlhepp W, Gold R, Rohrbach E, Mertens HG. Histopathological findings in the central and peripheral nervous systems in neuroborreliosis. A report of three cases. J Neurol 1990; 237: 113-6.
42. Midgard R, Hofstad H. Unusual manifestations of nervous system Borrelia burgdorferi infection. Arch Neurol 1987; 44: 781-3.
43. Miklossy J, Kasas S, Janzer RC, Ardizzoni F, Van der Loos H. Further ultrastructural evidence that spirochaetes may play a role in the aetiology of Alzheimer's disease. Neuroreport 1994; 5: 1201-4.
44. Millner MM, Mullegger RR, Spork KD, Stanek G. Lyme borreliosis of central nervous system (CNS) in children: a diagnostic challenge. Infection 1991; 19: 273-8.
45. Mokry M, Flaschka G, Kleinert G, Kleinert R, Fazekas F, Kopp W. Chronic Lyme disease with an expansive granulomatous lesion in the cerebellopontine angle. Neurosurgery 1990; 27: 446-51.
46. Moody KD, Barthold SW, Terwilliger GA, Beck DS, Hansen GM, Jacoby RO. Experimental chronic Lyme borreliosis in Lewis rats. Am J Trop Med Hyg 1990a; 42: 165-74.
47. Moody KD, Barthold SW, Terwilliger GA. Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am J Trop Med Hyg 1990b; 43: 87-92.
48. Mourin S, Bonnier C, Bigaignon G, Lyon G. Epilepsy disclosing neuroborreliosis. [French]. Rev Neurol (Paris) 1993; 149: 489-91.
49. Nadelman RB, Schwartz I, Wormser GP. Detecting Borrelia burgdorferi in blood from patients with Lyme disease [letter: comment). J Infect Dis 1994; 169: 1410-1. Comment on: J Infect Dis 1993; 168: 1541-3.
50. Nadelman RB, Schwartz I, Wormser GP. Detecting Borrelia burgdorferi in blood from patients with Lyme disease [letter: comment). J Infect Dis 1994; 169: 1410-1. Comment on: J Infect Dis 1993; 168: 1541-3.
51. Oksi J. Lyme borreliosis [letter; comment]. Lancet 1995; 345: 1437. Comment on: Lancet 1995; 345: 842-4.
52. Oksi J. Lyme borreliosis [letter; comment]. Lancet 1995; 345: 1437. Comment on: Lancet 1995; 345: 842-4.
53. Oksi J, Mertsola J, Reunanen M, Marjamäki M, Viljanen MK. Subacute multiple-site osteomyelitis caused by Borrelia burgdorferi. Clin Infect Dis 1994; 19: 891-6.
54. Oksi J, Uksila J, Marjamäki M, Nikoskelainen J, Viljanen MK, Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and P39 protein in patients with PCR-or culture-proven late Lyme borreliosis. J Clin Microbiol 1995a; 33: 2260-4.
55. Oksi J, Marjamäki M, Koski K, Nikoskelainen J, Viljanen MK. Bilateral facial palsy and meningitis caused by Borrelia double infection [Letter]. Lancet 1995b; 345: 1583-4.
56. Oksi J, Savolainen J, Pène J, Bosquet J, Laippala P, Viljanen MK. Decreased interleukin-4 and increased gamma Interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis. Infect Immun 1996; 64: 3620-23.
57. Olson JC, Esterly NB. Urticarial vasculitis and Lyme disease [see comments]. J Am Acad Dermatol 1990; 22: 1114-6.
58. Pachner AR, Delaney E. The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis. Ann Neurol 1993; 34: 544-50.
59. Pachner AR, Itano A. Borrelia burgdorferi infection of the brain: characterization of the organism and response to antibiotics and immune sera in the mouse model [see comments]. Neurology 1990; 40: 1535-40. Comment in: Neurology 1991; 41: 463.
60. Pachner AR, Itano A. Borrelia burgdorferi infection of the brain: characterization of the organism and response to antibiotics and immune sera in the mouse model [see comments]. Neurology 1990; 40: 1535-40. Comment in: Neurology 1991; 41: 463.
61. Pachner AR, Duray P, Steere AC. Central nervous system manifestations of Lyme disease. Arch Neurol 1989; 46: 790-5.
62. Pfister HW, Preac-Mursic V, Wilske B, Einhaupl KM, Weinberger K. Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs. Neurology 1989; 39: 1118-20.
63. Picken RN. Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J Clin Microbiol 1992; 30: 99-114.
64. Reik L Jr, Smith L, Khan A, Nelson W. Demyelinating encephalopathy in Lyme disease. Neurology 1985; 35: 267-9.
65. Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 1990; 335: 312-5.
66. Sellati TJ, Burns MJ, Ficazzola MA, Furie MB. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect Immun 1995; 63: 4439-47.
67. Sigal LH. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein. J Infect Dis 1993; 167: 1372-8.
68. Sigal LH, Tatum AH. Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology 1988; 38: 1439-42.
69. Smith JL, Winward KE, Nicholson DF, Albert DW. Retinal vasculitis in Lyme borreliosis. J Clin Neuroophthalmol 1991; 11: 7-15.
70. Somer T, Finegold SM. Vasculitides associated with infections, immunization, and antimicrobial drugs. [Review]. Clin Infect Dis 1995; 20: 1010-36.
71. Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990; 161: 1203-9.
72. Steere AC, Kalish RA, Kaplan RF, Taylor E, Logigian EL. Clinical manifestations of Lyme disease: Chronic arthritis and encephalopathy. In: Cevenini R, Sambri V, La Placa M, editors. Proceedings of the VI International Conference on Lyme Borreliosis. Bologna: Società Editrice Esculapio, 1994: 127-31.
73. Szczepanski A, Furie MB, Benach JL, Lane BP, Fleit HB. Interaction between Borrelia burgdorferi and endothelium in vitro. J Clin Invest 1990; 85: 1637-47.
74. Uldry PA, Regli F, Bogousslavsky J. Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection [letter]. J Neurol Neurosurg Psychiatry 1987; 50: 1703-4.
75. Veenendaal-Hilbers JA, Perquin WV, Hoogland PH, Doornbos L. Basal meningovasculitis and occlusion of the basilar artery in two cases of Borrelia burgdorferi infection. Neurology 1988; 38: 1317-9.
76. Viljanen MK, Punnonen J. The effect of storage of antigen-coated polystyrene microwells on the detection of antibodies against Borrelia burgdorferi by enzyme immunoassay (EIA). J Immunol Methods 1989; 124: 137-41.
77. Viljanen MK, Oksi J, Salomaa P, Skurnik M, Peltonen R, Kalimo H. Cultivation of Borrelia burgdorferi from the blood and a subcutaneous lesion of a patient with relapsing febrile nodular nonsuppurative panniculitis [letter]. J Infect Dis 1992; 165: 596-7.
78. Wallich R, Moter SE, Simon MM, Ebnet K, Heiberger A, Kramer MD. The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene. Infect Immun 1990; 58: 1711-9.
79. Weber K, Bratzke HJ, Neubert U, Wilske B, Duray PH. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 1988; 7: 286-9.
80. Weder B, Wiedersheim P, Matter L, Steck A, Otto F. Chronic progressive neurological involvement in Borrelia burgdorferi infection. J Neurol 1987; 234: 40-3.
81. Wokke JH, van Gijn J, Elderson A, Stanek G. Chronic forms of Borrelia burgdorferi infection of the nervous system. Neurology 1987; 37: 1031-4.
82. Yssel H, Shanafelt MC, Soderberg C, Schneider PV, Anzola J, Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 1991; 174: 593-601.